Lutz Froelich is an expert in Neurology at Central Institute of Mental Health (Germany). As of October 2026, ScienceLeadR ranks Lutz Froelich in the top 1% of experts worldwide for Alzheimer Disease, Dementia and Neurocognitive Disorders. Lutz Froelich has authored 554 publications, the most recent in 2026, and is an investigator in 9 clinical trials. SLR score: 1,446 (community average: 125). How the SLR is computed.

LeadR Profile

1 446 ScienceLeadR Reputation 1446
Network Map

Neurology

Subspecialties: Psychiatry - Geriatrics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1982 - 2026

Source: PubMed

Heidelberg University (Germany)

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 554

Citations

Citations: 42 674 1st author: 48 Last author: 70 Unique author: 10


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
CSF proteomic quantitative trait loci mapping reveals genetic insights into Alzheimer's disease.
PMID 42761049 — genetic variation, genes, alzheimer disease, quantitative trait loci
Mol Neurodegener Adv20260
From Proof of Principle to Therapeutic Discipline: Strategies to Improve the Benefit/Risk Profile of Amyloid-Targeting Treatments for Alzheimer's Disease.
PMID 42742914 — alzheimer disease, pharmaceutical preparations, work, therapeutics, amyloid
CNS Drugs20260
Cost-effectiveness of the special care unit for persons with dementia.
PMID 42566821 — dementia, alzheimer disease, quality-adjusted life years
J Prev Alzheimers Dis20260
Attitudes of specialist memory-clinic patients with early symptomatic Alzheimer's disease towards lecanemab: results from a multicenter survey in Europe.
PMID 42426158 — sample size, alzheimer disease, therapeutics, memory
Sci Rep20260
Investigating hepatitis E virus seroprevalence in patients with Alzheimer's disease.
PMID 42182563 — hepatitis e virus, alzheimer disease, cognitive dysfunction, aged, cognition disorders, viruses, hepatitis e, hepatitis
Front Aging Neurosci20260

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 3
Phase 3 3
Phase 2 1
Phase 2/Phase 3 1
Phase 4 1

By status:

Completed 7
Active not recruiting 1
Unknown 1

By type:

Interventional 8
Observational 1

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 1
multicentricup10 5

Main Topics

Cohort/Consortium Investigators 5

LeadR Networks

Main global connection map